Sorbitol: Clinical Trials

8 trials of Sorbitol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 recruiting, 1 terminated, 1 unknown. 8 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 5, Recruiting 1, Terminated 1, Unknown 1
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1

Follow Sorbitol: new trials by email Literature Review of Sorbitol trials Research Report on Sorbitol

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Intravenous oxytocin, Intravenous placebo, Intranasal oxytocin - Pain, Acute
Phase 2CompletedWake Forest University Health Sciences242025-11-052026-06-30
Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer
Sorbitol + PD-1 inhibitor + SOX chemotherapy, PD-1 inhibitor + SOX chemotherapy - Gastric Junction Adenocarcinoma, Gastric Cancer
Phase 2RecruitingUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology862024-11-012026-08-18
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
Hydroxychloroquine + Metabolic cofactor supplementation, Hydroxychloroquine + Sorbitol - COVID-19
Phase 2 / Phase 3TerminatedScandiBio Therapeutics AB1002020-09-212025-02-10
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
Metabolic Cofactor Supplementation, Sorbitol - Alzheimer Disease, Parkinson Disease
Phase 2CompletedIstanbul Medipol University Hospital1202019-12-022022-08-08
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
Metabolic Cofactor Supplementation, Sorbitol - Non-alcoholic Fatty Liver Disease (NAFLD)
Phase 2CompletedScandiBio Therapeutics AB322019-07-202025-02-10
Gait Analysis Following Knee Viscosupplementation
hyaluronic acid with mannitol, hyaluronic acid with sorbitol, Placebos - Gait, Knee Osteoarthritis
Phase 2 / Phase 3CompletedBrigitte Jolles, MD222013-05-012018-08-17
Effect of Xylitol on Oral Microbiota in Children
xylitol, sorbitol - Bacterial Infections
Phase 1 / Phase 2CompletedKuwait University1222012-03-012015-08-10
Effect of Erythritol and Xylitol on Dental Caries Prevention in Children
A, erythritol, xylitol, C, sorbitol - Dental Caries
Phase 2 / Phase 3UnknownUniversity of Tartu4502008-01-012010-02-04

Conditions studied

Acute Pain (1)  ·  Agnosia (1)  ·  Alzheimer Disease (1)  ·  Bacterial Infections (1)  ·  COVID-19 (1)  ·  Dental Caries (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Osteoarthritis, Knee (1)  ·  Parkinson Disease (1)  ·  Stomach Neoplasms (1)

Sponsors

ScandiBio Therapeutics AB (2)  ·  Brigitte Jolles, MD (1)  ·  Istanbul Medipol University Hospital (1)  ·  Kuwait University (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)  ·  University of Tartu (1)  ·  Wake Forest University Health Sciences (1)

Countries

Turkey (Türkiye) (3)  ·  China (1)  ·  Estonia (1)  ·  Kuwait (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Eino Honkala, PhD (2)  ·  Brigitte Brigitte (1)  ·  Burak Yulug, MD, PhD (1)  ·  James C Eisenach, MD (1)  ·  Lutfu Hanoglu, MD, PhD (1)  ·  Mare Saag, PhD (1)

Results publications

PMID 22607272, PMID 24095985, PMID 24852946, PMID 27806364, PMID 30999906, PMID 31024734, PMID 34694070, PMID 36703196, PMID 39816194